Medgenics (MDGN) Tops Q3 EPS by 1c

Medgenics (NASDAQ: MDGN) reported Q3 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Medgenics (MDGN) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Live Ventures (LIVE) Reports Q3 Loss of $0.34
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating